Pravin Dugel - Net Worth and Insider Trading
Pravin Dugel Net Worth
The estimated net worth of Pravin Dugel is at least $6 Million dollars as of 2024-06-09. Pravin Dugel is the See Remarks of Ocular Therapeutix Inc and owns about 833,353 shares of Ocular Therapeutix Inc (OCUL) stock worth over $4 Million. Pravin Dugel is also the EVP, Chief Strategy & Business of IVERIC bio Inc and owns about 41,699 shares of IVERIC bio Inc (ISEE) stock worth over $2 Million. Details can be seen in Pravin Dugel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pravin Dugel has not made any transactions after 2024-05-23 and currently still holds the listed stock(s).
Transaction Summary of Pravin Dugel
Pravin Dugel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pravin Dugel owns 3 companies in total, including Aerpio Pharmaceuticals Inc (ARPO) , IVERIC bio Inc (ISEE) , and Aadi Bioscience Inc (AADI) .
Click here to see the complete history of Pravin Dugel’s form 4 insider trades.
Insider Ownership Summary of Pravin Dugel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARPO | Aerpio Pharmaceuticals Inc | 2020-06-24 | director |
| ISEE | IVERIC bio Inc | 2021-04-05 | EVP & Chief Strategy & Business |
| AADI | Aadi Bioscience Inc | 2017-03-15 | director |
Pravin Dugel Latest Holdings Summary
Pravin Dugel currently owns a total of 2 stocks. Among these stocks, Pravin Dugel owns 833,353 shares of Ocular Therapeutix Inc (OCUL) as of May 23, 2024, with a value of $4 Million and a weighting of 71.19%. Pravin Dugel also owns 41,699 shares of IVERIC bio Inc (ISEE) as of April 5, 2021, with a value of $2 Million and a weighting of 28.81%.
Latest Holdings of Pravin Dugel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-05-23 | 833,353 | 4.94 | 4,116,764 |
| ISEE | IVERIC bio Inc | 2021-04-05 | 41,699 | 39.95 | 1,665,875 |
Holding Weightings of Pravin Dugel
Pravin Dugel Form 4 Trading Tracker
According to the SEC Form 4 filings, Pravin Dugel has made a total of 1 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ocular Therapeutix Inc is the sale of 21,626 shares on May 23, 2024, which brought Pravin Dugel around $125,215.
According to the SEC Form 4 filings, Pravin Dugel has made a total of 1 transactions in IVERIC bio Inc (ISEE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in IVERIC bio Inc is the sale of 28,301 shares on April 5, 2021, which brought Pravin Dugel around $179,428.
Insider Trading History of Pravin Dugel
- 1
Pravin Dugel Trading Performance
Pravin Dugel Ownership Network
Pravin Dugel Owned Company Details
What does Aerpio Pharmaceuticals Inc do?
Who are the key executives at Aerpio Pharmaceuticals Inc?
Pravin Dugel is the director of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .
Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerpio Pharmaceuticals Inc Insider Transactions
Pravin Dugel Mailing Address
Above is the net worth, insider trading, and ownership report for Pravin Dugel. You might contact Pravin Dugel via mailing address: C/o Aerpio Pharmaceuticals, Inc., 9987 Carver Road, Cincinnati Oh 45242.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
